BRICS Pharmaceutical Markets: A Step Towards Enhanced Cooperation
Meeting the Challenges of Competition Issues
The BRICS Working Group on research of competition issues in pharmaceutical markets will convene in Wuhan, China, on September 9, 2024. This gathering, part of Russia’s Chairship, will take place within the Fair Competition Conference of the People’s Republic of China. Moreover, the assembly will unite representatives from BRICS competition authorities and leaders of prominent drug companies from China and Russia.
Enhancing Access to Biological Products in Developing Countries
The meeting will provide a platform for participants to discuss topics like price regulation in drug markets and improving access to biological products in developing countries. Additionally, it will examine prospects for developing cooperation among BRICS nations in this field. Additionally, the event will enable a comprehensive discussion of competition issues in the BRICS Pharmaceutical Markets, ultimately enhancing the well-being of citizens in these countries.
Fostering Cooperation Among BRICS Countries
The co-chairs, FAS Russia and the State Administration for Market Regulation of China, will play a crucial role in ensuring the success of this meeting on competition issues in pharmaceutical markets. Furthermore, the Roscongress Foundation, responsible for managing events during Russia’s BRICS chairship, will offer essential support. Their combined efforts aim to make this gathering a success, benefiting the BRICS Pharmaceutical Markets.
Promoting Fair Competition in Pharmaceutical Markets
The BRICS Working Group’s meeting addresses growing concerns about competition issues in the pharmaceutical sector, holding paramount importance. Participants will exchange valuable insights and experiences, thus promoting fair competition in the drug industry. Subsequently, this collaboration strives to benefit consumers across the BRICS Pharmaceutical Markets, enhancing access to affordable and quality medications. Moreover, the gathering will explore innovative solutions to tackle challenges in these emerging economies’ medicinal product landscapes.
Fostering Innovation in the Pharmaceutical Industry
The BRICS Pharmaceutical Markets meeting will foster innovation in the drug industry by promoting collaboration among member countries. Participants will explore ways to develop new and effective treatments, addressing the increasing disease burden in these nations. Consequently, this gathering aims to facilitate the creation of novel medicines and therapies, ultimately enhancing health outcomes for citizens. Furthermore, the event will tackle competition issues in the pharmaceutical sector, promoting a more equitable and innovative market landscape.